Delivery Order SPE2DB20D1100-SPE2DB24FD2G9
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,683.61 firm-fixed-price contract is for the supply of Ondansetron Hydrochloride 8 mg tablets, a medication commonly used to prevent nausea and vomiting. The contract has an ultimate completion date of August 13, 2024. Amerisourcebergen, through its Corporate Office division, has been awarded this delivery order as part of a larger Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $41,872.79 firm fixed-price contract is for the supply of Ondansetron HCL 4 mg tablets, which are used to treat nausea and vomiting. The contract has a performance period through July 16, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ondansetron HCL 8 mg tablets, a prescription medication used to treat nausea and vomiting, at a ceiling value of $3,050.91. The contract has an ultimate completion date of August 13, 2024 and is a firm fixed-price delivery order. AmerisourceBergen, through its corporate office division, has been...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the supply of Ondansetron HCL 8 mg tablets, a pharmaceutical product used to treat nausea and vomiting. The contract has a firm fixed price of $4,045.41 and a performance period ending on May 15, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a...
- This is a $14,374.29 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,564,997 units of 8 mg Ondansetron HCl tablets, a medication used to prevent nausea and vomiting. The contract has an ultimate completion date of June 26, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,563,093,192 units of Ondansetron HCL 8 mg tablets, a medication used to prevent nausea and vomiting. The $2,958.33 firm-fixed-price contract has a completion date of December 14, 2023 and is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $10,079.55 contract is for the supply of 4 milligram Ondansetron orally disintegrating tablets, a common medication used to prevent nausea and vomiting. The contract has a completion date of January 25, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $17,983.83 and is for the delivery of Ondansetron HCL 8 mg tablets. The contract is a firm fixed price delivery order with a completion date of February 26, 2024. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp holds a significant...
- This is a $10,773.89 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the provision of Ondansetron ODT 8 mg Tablets, a medication used to treat nausea and vomiting, to support military healthcare programs. The contract has an ultimate completion date of June 17, 2024. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Ondansetron ODT 8 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $4,988.22 and an ultimate completion date of August 1, 2024. The contract is a firm fixed-price type and does not have a set-aside designation. Amerisourcebergen holds a significant...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FD2G9Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ondansetron HCL 8 mg tablets, a medication used to treat nausea and vomiting. The contract has a firm fixed price of $1,503.07 and an ultimate completion date of August 13, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp, through its Corporate Office division, has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs) to provide a wide range of pharmaceutical products and medical supplies to support various government agencies and healthcare programs, including the military. The company's extensive supply chain capabilities and experience in government contracting make it well-positioned to fulfill this delivery order.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 8/12/24 |